Centiva Capital’s NEOPHOTONICS CORP NPTN Stock Holding History

Centiva Capital’s Portfolio NPTN Stock Details NPTN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-113,076	Closed	-$1.78M	–	2038
2022 Q2	$1.78M	Buy	113,076 +13,076	+13%	+$200K	0.04%	394
2022 Q1	$1.52M	Buy	100,000 +13,249	+15%	+$202K	0.03%	533
2021 Q4	$1.33M	Buy	+86,751	New	+$1.14M	0.03%	496
2020 Q3	–	Sell	-18,658	Closed	-$166K	–	927
2020 Q2	$166K	Buy	+18,658	New	+$161K	0.01%	545

Other funds holding NPTN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return

Centiva Capital's NPTN Position: Q3 2022 in Review

Centiva Capital sold out of NEOPHOTONICS CORP (NPTN) in Q3 2022, closing a stake of 113,076 shares — an estimated $1.78M sold.

Centiva Capital first reported a position in NPTN in Q2 2020 and held it in 4 quarters. The position peaked at $1.78M in Q2 2022. 2 funds tracked by Wall St. Rank hold NPTN as of Q3 2022.

Centiva Capital reported no remaining NEOPHOTONICS CORP position as of Q3 2022 after selling out during the quarter.
Centiva Capital sold 113,076 NEOPHOTONICS CORP shares in Q3 2022, an estimated $1.78M.
Centiva Capital first reported a position in NEOPHOTONICS CORP in Q2 2020 and held it in 4 quarters.
Centiva Capital's NEOPHOTONICS CORP position peaked at $1.78M in Q2 2022.
2 funds tracked by Wall St. Rank held NEOPHOTONICS CORP as of Q3 2022.

Based on Centiva Capital's 13F filing for Q3 2022, filed 14 Nov 2022.